Tdpoz4 inhibitors are a class of chemical compounds characterized by their specific interaction with the Tdpoz4 enzyme, a protein whose activity is crucial in a particular biological pathway. These inhibitors are designed to bind to the active site or another relevant domain of the Tdpoz4 enzyme, blocking its action by either competitive or non-competitive means. In competitive inhibition, the inhibitor resembles the enzyme's natural substrate and competes for binding at the active site, while in non-competitive inhibition, the inhibitor binds to a different part of the enzyme, causing a conformational change that reduces the enzyme's activity. The specificity of Tdpoz4 inhibitors is a result of meticulous molecular design, which ensures that the interaction with the enzyme is both strong and selective, thereby modulating the function of Tdpoz4 without significantly affecting other enzymes.
The development and study of Tdpoz4 inhibitors are rooted in a deep understanding of the enzyme's structure and function. Structural biology techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy provide detailed insights into the three-dimensional configuration of Tdpoz4, allowing chemists to tailor inhibitors that fit like a lock and key. The chemical composition of Tdpoz4 inhibitors often includes rings and chains that mimic the natural substrates or products of the Tdpoz4-catalyzed reaction. Additionally, these inhibitors may possess functional groups that engage in hydrogen bonding, electrostatic interactions, or hydrophobic contacts with the enzyme, which further stabilize the inhibitor-enzyme complex. The design process is typically iterative, with initial inhibitor prototypes being refined over multiple rounds of synthesis and binding assays to enhance their potency and selectivity for Tdpoz4.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A tyrosine kinase inhibitor that could inhibit Src family kinases. If Tdpoz4 activity is modulated by Src kinases through phosphorylation, Dasatinib could result in decreased Tdpoz4 function. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor, Gefitinib can block the EGFR signaling pathway, which could lead to a reduction in the activity of downstream proteins such as Tdpoz4 if it is implicated in this pathway. | ||||||